The Authors Respond

J Manag Care Spec Pharm. 2020 Sep;26(9):1177-1178. doi: 10.18553/jmcp.2020.26.9.1177a.


No funding was received for the writing of this letter. Simpson reports consulting honoraria for participation in advisory boards for Bayer, CSL Behring, HEMA Biologics, Novo Nordisk, Octapharma and Takeda, and speakers bureau for Bayer and Novo Nordisk; Yan and Desai are employees of CSL Behring; Maro is an employee of Adivo Associates.

Publication types

  • Letter
  • Comment